Vol. 6 No. 1 (2026)
Reimbursement Recommendations

Aripiprazole

decorative image of the issue cover

Published January 27, 2026

Key Messages

  • The Formulary Management Expert Committee (FMEC) recommends that oral aripiprazole be reimbursed as an adjunct to antidepressants for the treatment of major depressive disorder (MDD) in adult patients who have an inadequate response to at least 1 prior antidepressant treatment.
  • The committee determined that there are no conditions necessary for the reimbursement recommendation.